Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 26 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Suspicion of Barrett's esophagus based on either endoscopy or histology only

In September's issue of Gut, the results of a follow up study into endoscopic and histologic procedures used in cases of suspicion of Barrett's esophagus are published.

News image

fiogf49gjkf04

The incidence of distal esophageal adenocarcinoma is rising and chronic reflux and Barrett’s esophagus are both considered risk factors.

At present, reliable detection of Barrett's esophagus dictates the use of upper endoscopy, but both endoscopy and histology are required for accurate confirmation.

Appropriate management of patients with endoscopic suspicion but with negative histology,or of patients with no endoscopic suspicion but with a biopsy diagnosis of intestinal metaplasia at the gastro-esophageal junction, has not yet been studied prospectively.

Researchers from The University of Munich in Germany carried out a prospective multicenter study in which a total of 929 patients (51% male, mean age 50 years) referred for upper gastrointestinal endoscopy were included.

59% of these patients had reflux symptoms.

Researchers noted the endoscopic aspect of the Z line and any suspicion of Barrett’s esophagus. Biopsies were then taken in all patients from the Z line (n = 4), gastric cardia (n = 2), and body and antrum (n = 2 each).

Only 10–20% of cases with either endoscopic or histological suspicion of Barrett’s esophagus had established Barrett's after 2.5 years of follow up
Gut

A reference pathologist reviewed cases in which biopsies were found positive for specialized intestinal metaplasia (SIM) for confirmation of a final Barrett’s esophagus diagnosis.

All patients with endoscopic and/or histological suspicion of Barrett’s esophagus were invited for a follow up endoscopy; the remaining cases (no endoscopic or histological suspicion of Barrett’s esophagus) were followed clinically.

Of the total 235 patients positive for Barrett’s esophagus on endoscopy and/or histology, 63% agreed to undergo repeat endoscopy.

46% of patients with an endoscopic Barrett’s esophagus diagnosis but no histological confirmation showed the same distribution.

A further 42% did not have Barrett’s esophagus, and 11% had confirmed Barrett’s esophagus on both endoscopy and biopsy on follow up.

In the group with a histological Barrett’s esophagus diagnosis who had no findings on initial endoscopy, follow up showed the same in 26% whereas 46% had no Barrett’s esophagus.

Confirmed Barrett’s esophagus (endoscopy plus histology) was diagnosed in 17% of these patients.

Of the study population, 16 patients had Barrett’s esophagus on initial endoscopy confirmed by histology which remained constant in 70% at follow up.

Of the remaining patients without an initial Barrett’s esophagus diagnosis on either endoscopy or histology and only clinical follow up, one confirmed Barrett’s esophagus case was found among 100 patients re-endoscoped outside of the study protocol.

However, no single case of dysplasia or cancer of the distal oesophagus was detected in any patient during the study period.

Professor Rosch commented,"Even in a specialised gastroenterology setting, reproducibility of presumptive endoscopic or histological diagnoses of Barrett’s oesophagus at follow up were poor."

In addition, "Only 10–20% of cases with either endoscopic or histological suspicion of Barrett’s oesophagus had established Barrett’s oesophagus after 2.5 years of follow up."

The group concluded that meticulous follow up may not be required as the risk of dysplasia in this population was shown to be very low.

Gut;2004:53:1402-1407
20 September 2004

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us